Novel Agent Reduces Bowel Movement Frequency in Carcinoid Syndrome
By A Mystery Man Writer
Description
Neuroendocrine neoplasms of the lung and gastrointestinal system: convergent biology and a path to better therapies
Carcinoid tumours of the small intestine
Life-threatening diarrhea in neuroendocrine tumors: two case reports, Journal of Medical Case Reports
Peripheral Selective Oxadiazolylphenyl Alanine Derivatives as
New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond
JCM, Free Full-Text
Gastrointestinal Neuroendocrine Tumors and the Carcinoid Syndrome
Novel Agent Reduces Bowel Movement Frequency in Carcinoid Syndrome
SEOM-GETNE clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2022)
Targeted Systemic Treatment of Neuroendocrine Tumors: Current Options and Future Perspectives
Vitamins
Measuring the Relationship of Quality of Life and Health Status
PDF) What Gastroenterologists Should Know about Carcinoid Syndrome
Time to Sustained Improvement in Bowel Movement Frequency with
Symptomatic assessment tools. The figure collects the different tools
from
per adult (price varies by group size)